摘要: Patients with chronic kidney disease and patients on renal replacement therapy, such as hemodialysis peritoneal dialysis, have an increased susceptibility to infectious diseases compared healthy subjects (Sarnak & Jaber 2000; Allon et al. 2003). Infection is also the second most common cause of morbidity mortality in end-stage (Bloembergen Port 1996; Powe 1999; Graff 2002). One contributing factor could be inflammatory activation seen which causes a refractoriness leukocytes when confronted invading microorganisms.
intechopen.com
intechweb.org 参考文章(114)
Haag-Weber M, Cohen G, Hörl Wh, Immune dysfunction in uremia. Kidney International. ,vol. 62, ,(1997)
B??atrice Descamps-Latscha, The immune system in end-stage renal disease Current Opinion in Nephrology and Hypertension. ,vol. 2, pp. 883- 891 ,(1993) , 10.1097/00041552-199311000-00005
Haag-Weber M, Hörl Wh, Dysfunction of polymorphonuclear leukocytes in uremia. Seminars in Nephrology. ,vol. 16, pp. 192- 201 ,(1996)
Steven M. Albelda, C. Wayne Smith, Peter A. Ward, Adhesion molecules and inflammatory injury. The FASEB Journal. ,vol. 8, pp. 504- 512 ,(1994) , 10.1096/FASEBJ.8.8.8181668
Ionut Nistor, Suetonia C Palmer, Jonathan C Craig, Valeria Saglimbene, Mariacristina Vecchio, Adrian Covic, Giovanni FM Strippoli, None, Haemodiafiltration, haemofiltration and haemodialysis for end‐stage kidney disease Cochrane Database of Systematic Reviews. ,(2015) , 10.1002/14651858.CD006258.PUB2
E. Dadfar, S. H. Jacobson, J. Lundahl, Newly recruited human monocytes have a preserved responsiveness towards bacterial peptides in terms of CD11b up-regulation and intracellular hydrogen peroxide production. Clinical and Experimental Immunology. ,vol. 148, pp. 573- 582 ,(2007) , 10.1111/J.1365-2249.2007.03373.X
Bernard M. Babior, NADPH Oxidase: An Update Blood. ,vol. 93, pp. 1464- 1476 ,(1999) , 10.1182/BLOOD.V93.5.1464
R. Vanholder, A. Argilés, U. Baurmeister, P. Brunet, W. Clark, G. Cohen, P.P. Dedeyn, R. Deppisch, B. Descamps-Latscha, T. Henle, A. Jörres, Z.A. Massy, M. Rodriguez, B. Stegmayr, P. Stenvinkel, M.L Wratten, Uremic toxicity: present state of the art. International Journal of Artificial Organs. ,vol. 24, pp. 695- 725 ,(2001) , 10.1177/039139880102401004
Bernard Canaud, Leila Chenine, Delphine Henriet, Hélène Leray, Cross-membrane flux is a major factor influencing dialysis patient outcomes. Contributions To Nephrology. ,vol. 161, pp. 178- 184 ,(2008) , 10.1159/000130675
Gerald Cohen, Walter H. Hörl, Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin. Seminars in Dialysis. ,vol. 22, pp. 373- 377 ,(2009) , 10.1111/J.1525-139X.2009.00583.X